Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2281 to 2295 of 9128 results

  1. Percutaneous insertion of a cerebral protection device during TAVI for preventing stroke

    In development Reference number: GID-HTG10881 Expected publication date:  11 February 2027

    HealthTech guidance
    In development

  2. Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]

    In development Reference number: GID-TA11221 Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment [ID6474]

    In development Reference number: GID-TA11613 Expected publication date: TBC

    Technology appraisal guidance
    In development

  4. Extravascular implantable cardioverter defibrillator insertion for preventing sudden cardiac death caused by ventricular arrhythmia

    In development Reference number: GID-HTG10882 Expected publication date:  08 April 2027

    HealthTech guidance
    In development

  5. Monofocal intraocular lenses for cataract surgery

    In development Reference number: GID-HTG10875 Expected publication date:  10 March 2027

    HealthTech guidance
    In development

  6. Inavolisib with pertuzumab–trastuzumab for maintenance treatment of PIK3CA-mutated HER2-positive advanced breast cancer after induction chemotherapy

    Awaiting development Reference number: GID-TA12441 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  7. Acalabrutinib with bendamustine and rituximab for untreated mantle cell lymphoma [ID6155]

    In development Reference number: GID-TA11091 Expected publication date:  04 June 2026

    Technology appraisal guidance
    In development

  8. CaRi-Heart for predicting cardiac risk in adults with suspected coronary artery disease (CAD)

    In development Reference number: GID-HTG10885 Expected publication date:  02 December 2026

    HealthTech guidance
    In development

  9. Vonaprument for treating geographic atrophy caused by age-related macular degeneration

    Awaiting development Reference number: GID-TA12454 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. PillCam COLON 2 for investigation of the colon through direct visualisation

    Deferred Reference number: GID-HTG10900

    HealthTech guidance
    Deferred

  11. Tanruprubart for treating Guillain–Barre syndrome in people 12 years and over

    Awaiting development Reference number: GID-TA12453 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Surgical mesh for treatment of primary ventral hernias

    In development Reference number: GID-HTG10876 Expected publication date:  24 June 2027

    HealthTech guidance
    In development

  13. Tafasitamab with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma after 1 or more systemic treatments [ID6413]

    In development Reference number: GID-TA11488 Expected publication date: TBC

    Technology appraisal guidance
    In development

  14. Digital technologies delivering CBT for insomnia in adults

    In development Reference number: GID-HTG10888 Expected publication date:  06 January 2027

    HealthTech guidance
    In development

  15. Sebetralstat for treating acute attacks of hereditary angioedema in people aged 12 and over [ID6284]

    In development Reference number: GID-TA11334 Expected publication date: TBC

    Technology appraisal guidance
    In development